tadalafil has been researched along with tipranavir in 2 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (tipranavir) | Trials (tipranavir) | Recent Studies (post-2010) (tipranavir) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 289 | 42 | 47 |
| Protein | Taxonomy | tadalafil (IC50) | tipranavir (IC50) |
|---|---|---|---|
| Protease | Human immunodeficiency virus 1 | 0.03 | |
| CAAX prenyl protease 1 homolog | Mus musculus (house mouse) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dellamonica, P; Durant, J; Ferrando, S; Garraffo, R; Lavrut, T; MacGregor, TR; Rouyrre, N; Sabo, JP | 1 |
1 review(s) available for tadalafil and tipranavir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for tadalafil and tipranavir
| Article | Year |
|---|---|
Effect of tipranavir/ritonavir combination on the pharmacokinetics of tadalafil in healthy volunteers.
Topics: Adult; Biological Availability; Carbolines; Cross-Over Studies; Drug Interactions; Half-Life; HIV Protease Inhibitors; Humans; Male; Metabolic Clearance Rate; Phosphodiesterase 5 Inhibitors; Pyridines; Pyrones; Ritonavir; Sulfonamides; Tadalafil; Young Adult | 2011 |